Cited 0 times in

The monocyte chemoattractant protein-1 (MCP-1)/CCR2 system is involved in peritoneal dialysis-related epithelial-mesenchymal transition of peritoneal mesothelial cells

Title
The monocyte chemoattractant protein-1 (MCP-1)/CCR2 system is involved in peritoneal dialysis-related epithelial-mesenchymal transition of peritoneal mesothelial cells
Other Titles
MCP-1/CCR2 시스템이 복막중피세포의 복막투석과 관련한 상피-중간엽 이행에 미치는 영향
Issue Date
2012
Publisher
Graduate School, Yonsei University
Description
Dept. of Medical Science/박사
Abstract
Background: Peritoneal fibrosis (PF) is a serious complication in long-term peritoneal dialysis (PD) patients, but the underlying mechanism is not well understood. Recently, accumulating evidences has suggested that epithelial-mesenchymal transition (EMT) is involved in a variety of fibrotic disorders, including renal fibrosis, pulmonary fibrosis, and PF. In addition, TGF-1 is known to plays an important role in the process of EMT. Meanwhile, recent studies have shown that monocyte chemoattractant protein-1 (MCP-1) directly increases TGF-1 production via C-C chemokine receptor 2 (CCR2) and the MCP-1/CCR2 system is implicated in high glucose-induced TGF-1 production in cultured mesangial cells. Since human peritoneal mesothelial cells (HPMCs) also synthesize MCP-1, there is a possibility that the interaction between the MCP-1/CCR2 system and the TGF-1 pathway is involved in EMT and extracellular matrix (ECM) synthesis in HPMCs, resulting in PF.Purpose: This study was undertaken to investigate the direct effect of MCP-1 on EMT and fibronectin expression and the role of the MCP-1/CCR2 system in high glucose- and TGF-1-induced EMT in cultured HPMCs. In addition, the impact of MCP-1/CCR2 inhibition on EMT and PF was elucidated in an animal model of PD.Methods: In vitro, HPMCs were incubated in M199 media containing 5.6 mM glucose (normal glucose, NG), NG+94.4 mM mannitol (NG+M), NG+recombinant human MCP-1 (10 ng/ml) (NG+MCP-1), or 100 mM glucose (high glucose, HG) with or without RS102895 (10 M), a specific chemical inhibitor of CCR2. In addition, dominant negative mutant MCP-1 (mMCP-1)-expressing lentivirus-transfected HPMCs were exposed to NG or NG+MCP-1 media. After 72 hours, cells were harvested and conditioned media were collected. In vivo, PD catheters were inserted into 60 Sprague-Dawley rats, and saline (C group, n=30) or 4.25% PD solution (PD group, n=30) were infused for 4 weeks. Twenty rats from each group were treated with empty lentivirus vector or lentivirus vector containing mMCP-1 intraperitoneally, every 5 days for 3 times, and 10 rats from each group were left untreated. After 4 weeks, rats were sacrificed and the peritoneal tissues were removed. E-cadherin, α-smooth muscle actin (α-SMA), and fibronectin protein expression in HPMCs and the peritoneum were evaluated by Western blot analysis, and fibronectin mRNA expression by real-time PCR. MCP-1 and TGF-1 concentrations in conditioned media were determined by ELISA. PF was assessed by Masson’s trichrome (MT) staining.Results: Compared to NG cells, E-cadherin expression was significantly decreased, while α-SMA and fibronectin expression were significantly increased in HPMCs exposed to HG and NG+MCP-1, and these changes were significantly abrogated by RS102895 treatment (p<0.05). RS102895 also significantly ameliorated the increase in TGF-1 levels in HG-conditioned media. In addition, TGF-1- and MCP-1-induced EMT were significantly attenuated by RS102895 and TGF-1 neutralizing antibody, respectively. In rats treated with PD solution for 4 weeks, the ratios of E-cadherin/α-SMA protein expression in the peritoneum were significantly decreased, whereas fibronectin mRNA and protein expression was significantly increased compared to C rats (p<0.05). The thickness of mesothelial layer and the intensity of MT staining in the peritoneum of PD rats were also significantly higher relative to C rats (p<0.05). These changes of the peritoneum in PD rats were significantly abrogated by the administration of lentivirus containing mMCP-1.Conclusions: These findings suggest that the MCP-1/CCR2 system is directly involved in PD-related EMT and ECM synthesis partly via TGF-1 and its inhibition may be a potential therapeutic strategy for PF in PD patients.
URI

http://ir.ymlib.yonsei.ac.kr/handle/22282913/133830
Appears in Collections:
2. 학위논문 > 1. College of Medicine (의과대학) > 박사
Yonsei Authors
사서에게 알리기
  feedback
Fulltext
교내이용자 서비스로 제공됩니다.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse